Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Aug 14;285(6340):461–462. doi: 10.1136/bmj.285.6340.461-a

Immune guided missiles.

T J Hamblin
PMCID: PMC1499285  PMID: 6809124

Full text

PDF
461

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DRESSER D. W., GOWLAND G. IMMUNOLOGICAL PARALYSIS INDUCED IN ADULT RABBITS BY SMALL AMOUNTS OF A PROTEIN ANTIGEN. Nature. 1964 Aug 15;203:733–736. doi: 10.1038/203733a0. [DOI] [PubMed] [Google Scholar]
  2. Ghose T., Norvell S. T., Guclu A., Cameron D., Bodurtha A., MacDonald A. S. Immunochemotherapy of cancer with chlorambucil-carrying antibody. Br Med J. 1972 Aug 26;3(5825):495–499. doi: 10.1136/bmj.3.5825.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Glennie M. J., Stevenson G. T. Univalent antibodies kill tumour cells in vitro and in vivo. Nature. 1982 Feb 25;295(5851):712–714. doi: 10.1038/295712a0. [DOI] [PubMed] [Google Scholar]
  4. Gordon J., Stevenson G. T. Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. II. Relationship to redistribution of the antigen. Immunology. 1981 Jan;42(1):13–17. [PMC free article] [PubMed] [Google Scholar]
  5. Greaves M., Delia D., Janossy G., Rapson N., Chessells J., Woods M., Prentice G. Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells. Leuk Res. 1980;4(1):15–32. doi: 10.1016/0145-2126(80)90044-2. [DOI] [PubMed] [Google Scholar]
  6. Hamblin T. J., Abdul-Ahad A. K., Gordon J., Stevenson F. K., Stevenson G. T. Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer. 1980 Oct;42(4):495–502. doi: 10.1038/bjc.1980.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hatzubai A., Maloney D. G., Levy R. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. J Immunol. 1981 Jun;126(6):2397–2402. [PubMed] [Google Scholar]
  8. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  9. Hough D. W., Eady R. P., Hamblin T. J., Stevenson F. K., Stevenson G. T. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes. J Exp Med. 1976 Oct 1;144(4):960–969. doi: 10.1084/jem.144.4.960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Krolick K. A., Uhr J. W., Vitetta E. S. Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation. Nature. 1982 Feb 18;295(5850):604–605. doi: 10.1038/295604a0. [DOI] [PubMed] [Google Scholar]
  11. Metzgar R. S., Borowitz M. J., Jones N. H., Dowell B. L. Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med. 1981 Oct 1;154(4):1249–1254. doi: 10.1084/jem.154.4.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Miller R. A., Levy R. Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet. 1981 Aug 1;2(8240):226–230. doi: 10.1016/s0140-6736(81)90475-x. [DOI] [PubMed] [Google Scholar]
  13. Miller R. A., Maloney D. G., McKillop J., Levy R. In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood. 1981 Jul;58(1):78–86. [PubMed] [Google Scholar]
  14. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  15. Moolten F. L., Capparell N. J., Zajdel S. H., Cooperband S. R. Antitumor effects of antibody-diphtheria toxin conjugates. II. Immunotherapy with conjugates directed against tumor antigens induced by simian virus 40. J Natl Cancer Inst. 1975 Aug;55(2):473–477. [PubMed] [Google Scholar]
  16. Nadler L. M., Stashenko P., Hardy R., Kaplan W. D., Button L. N., Kufe D. W., Antman K. H., Schlossman S. F. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 1980 Sep;40(9):3147–3154. [PubMed] [Google Scholar]
  17. Nord S., Weissman I. L. Radiolabeled antitumor antibodies. III. Highly iodinated and highly radioiodinated antibodies. J Natl Cancer Inst. 1974 Oct;53(4):959–965. doi: 10.1093/jnci/53.4.959. [DOI] [PubMed] [Google Scholar]
  18. Ritz J., Pesando J. M., Sallan S. E., Clavell L. A., Notis-McConarty J., Rosenthal P., Schlossman S. F. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood. 1981 Jul;58(1):141–152. [PubMed] [Google Scholar]
  19. Rosenberg S. A., Terry W. D. Passive immunotherapy of cancer in animals and man. Adv Cancer Res. 1977;25:323–388. doi: 10.1016/s0065-230x(08)60637-5. [DOI] [PubMed] [Google Scholar]
  20. Rubens R. D., Dulbecco R. Augmentation of cytotoxic drug action by antibodies directed at cell surface. Nature. 1974 Mar 1;248(5443):81–82. doi: 10.1038/248081a0. [DOI] [PubMed] [Google Scholar]
  21. Stevenson F. K., Hamblin T. J., Stevenson G. T., Tutt A. L. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med. 1980 Dec 1;152(6):1484–1496. doi: 10.1084/jem.152.6.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stevenson G. T., Elliott E. V., Stevenson F. K. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc. 1977 Aug;36(9):2268–2271. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES